Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Microvesicle-camouflaged biomimetic nanoparticles encapsulating a metal-organic framework for targeted rheumatoid arthritis therapy

Fig. 4

Cellular uptake of rhodamine B (Rhm B)-labeled formulations by A Non-activated and B LPS-activated RAW264.7 cells, as determined by flow cytometry. The horizontal axis indicates fluorescence intensity and the vertical axis cell indices counts. C Uptake rate of different preparations, as determined by flow cytometry. Data are shown as mean ± SD (n = 3). ***P < 0.001. FPD: 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate (polyethylene glycol)-2000; LPS: lipopolysaccharide; MV: microvesicle; ZIF-8: zeolitic imidazolate framework-8

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us